Executive CMO - Production Co-ordinator
Bliss GVS Pharma Ltd.
Mumbai, Maharashtra
Vijay Dalavi serves as Executive CMO - Production Co-ordinator at Bliss GVS Pharma Ltd.. Bliss GVS Pharma Ltd. operates in the pharmaceuticals sector with approximately 970.0 employees. The company is headquartered in Mumbai, Maharashtra. Bliss GVS Pharma Ltd. generates annual revenue of 22622000.0.
Executives like Vijay Dalavi in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Bliss GVS Pharma Ltd..
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.
Vijay Dalavi's verified email address is available to MessageCEO Pro subscribers. They currently serve as Executive CMO - Production Co-ordinator at Bliss GVS Pharma Ltd.. Access direct contact info to skip gatekeepers and reach the decision maker.
Vijay Dalavi is Executive CMO - Production Co-ordinator at Bliss GVS Pharma Ltd., a company in the pharmaceuticals sector with 970.0 employees. The company is based in Mumbai, Maharashtra.
As Executive CMO - Production Co-ordinator at Bliss GVS Pharma Ltd., Vijay Dalavi is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Vijay Dalavi directly — ideal for B2B sales, partnerships, and executive recruiting.
Vijay Dalavi works in the pharmaceuticals industry as Executive CMO - Production Co-ordinator at Bliss GVS Pharma Ltd.. MessageCEO provides verified contact information for executives across all major industries.
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Vijay Dalavi's profile is kept up-to-date with the latest available information.